 DOLONEUTIN
|
Géminis Farmacéutica
|
| pregabalina |
Antiepiléptico |
| 25 mg cáps.x 30 | $13.773,90 | (29/09/26) |
| PAMI |
|
| AF $6.818,76 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.262,08 AF $6.511,82 |
|
|
|
|
| 50 mg cáps.x 30 | $29.603,91 | (29/09/26) |
| PAMI |
|
| AF $13.988,84 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.449,24 AF $14.154,67 |
|
|
|
|
| 75 mg cáps.x 15 | $21.679,26 | (29/09/26) |
| PAMI |
|
| AF $9.208,71 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $10.600,45 AF $11.078,81 |
|
|
|
|
| 75 mg cáps.x 30 | $38.003,51 | (29/09/26) |
| PAMI |
|
| AF $18.813,62 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.932,47 AF $18.071,04 |
|
|
|
|
| 150 mg cáps.x 30 | $60.345,06 | (29/09/26) |
| PAMI |
|
| AF $29.671,72 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.989,52 AF $32.355,54 |
|
|
|
|
| 300 mg cáps.x 30 | $85.689,86 | (29/09/26) |
| PAMI |
|
| AF $33.936,93 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $41.488,21 AF $44.201,65 |
|
|
|
|
| |
